resveratrol has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, LK; Dedousis, N; Dolinsky, VW; Han, X; Hatch, GM; Kaufman, BA; Mejia, EM; Sparagna, GC; Vandel, M; Xiang, B | 1 |
1 other study(ies) available for resveratrol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy.
Topics: Animals; Biomarkers; Cardiolipins; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Disease Susceptibility; Echocardiography; Electron Transport Complex I; Heart Function Tests; Immunohistochemistry; Lipid Metabolism; Male; Mice; Mice, Transgenic; Mitochondria; Mitochondria, Heart; Oxidative Stress; Reactive Oxygen Species; Resveratrol | 2020 |